Consumer healthcare products giant Glaxosmithkline Consumer Healthcare Ltd has done a HUL, registering a near 16 per cent increase in sales in the quarter ended March 31, 2013.

It is the first quarter for the current year for the company as it follows a Jan-Dec fiscal.

Net profit during the period has gone up about 20 per cent compared to the corresponding quarter in the previous financial year.

According to the standalone unaudited results for the quarter ended March 31, 2013, the total income from operations (net) was Rs 975.38 crore against Rs 836.41 crore during the same period in the previous financial year.

Net profit for the quarter was Rs 156.41 crore against Rs 131.97 crore in the corresponding quarter during last year. EPS (share face value Rs 10) for the quarter was also sharply up at Rs 37.19 (Rs 31.38).

(This article was published on May 2, 2013)
XThese are links to The Hindu Business Line suggested by Outbrain, which may or may not be relevant to the other content on this page. You can read Outbrain's privacy and cookie policy here.